Literature DB >> 16556512

Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases.

Paul L R Andrews1, Charles C Horn.   

Abstract

Nausea and vomiting are amongst the most common symptoms encountered in medicine as either symptoms of diseases or side effects of treatments. In a more biological setting they are also important components of an organism's defences against ingested toxins. Identification of treatments for nausea and vomiting and reduction of emetic liability of new therapies has largely relied on the use of animal models, and although such models have proven invaluable in identification of the anti-emetic effects of both 5-hydroxytryptamine(3) and neurokinin(1) receptor antagonists selection of appropriate models is still a matter of debate. The present paper focuses on a number of controversial issues and gaps in our knowledge in the study of the physiology of nausea and vomiting including: The choice of species for the study of emesis and the underlying behavioural (e.g. neophobia), anatomical (e.g. elongated, narrow abdominal oesophagus with reduced ability to shorten) and physiological (e.g. brainstem circuitry) mechanisms that explain the lack of a vomiting reflex in certain species (e.g. rats); The choice of response to measure (emesis[retching and vomiting], conditioned flavour avoidance or aversion, ingestion of clay[pica], plasma hormone levels[e.g. vasopressin], gastric dysrhythmias) and the relationship of these responses to those observed in humans and especially to the sensation of nausea; The stimulus coding of nausea and emesis by abdominal visceral afferents and especially the vagus-how do the afferents encode information for normal postprandial sensations, nausea and finally vomiting?; Understanding the central processing of signals for nausea and vomiting is particularly problematic in the light of observations that vomiting is more readily amenable to pharmacological treatment than is nausea, despite the assumption that nausea represents "low" intensity activation of pathways that can evoke vomiting when stimulated more intensely.

Entities:  

Mesh:

Year:  2006        PMID: 16556512      PMCID: PMC2658708          DOI: 10.1016/j.autneu.2006.01.008

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  195 in total

1.  Stomach rinsing in rays.

Authors:  D W Sims; P L Andrews; J Z Young
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Transneuronal tracing of neural pathways controlling activity of diaphragm motoneurons in the ferret.

Authors:  B J Yates; J A Smail; S D Stocker; J P Card
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

3.  Conditioned taste aversion and motion sickness in cats and squirrel monkeys.

Authors:  R A Fox; M Corcoran; K R Brizzee
Journal:  Can J Physiol Pharmacol       Date:  1990-02       Impact factor: 2.273

4.  Spectral analysis of tachygastria recorded during motion sickness.

Authors:  R M Stern; K L Koch; W R Stewart; I M Lindblad
Journal:  Gastroenterology       Date:  1987-01       Impact factor: 22.682

5.  Role of the area postrema in radiation-induced taste aversion learning and emesis in cats.

Authors:  B M Rabin; W A Hunt; A L Chedester; J Lee
Journal:  Physiol Behav       Date:  1986

6.  Clay ingestion (geophagia) as a source of zinc for rats.

Authors:  J C Smith; J A Halsted
Journal:  J Nutr       Date:  1970-08       Impact factor: 4.798

7.  Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis.

Authors:  H Tsukada; T Hirose; A Yokoyama; Y Kurita
Journal:  Eur J Cancer       Date:  2001-12       Impact factor: 9.162

8.  Effect of morphine on gastroesophageal reflux and transient lower esophageal sphincter relaxation.

Authors:  R Penagini; P A Bianchi
Journal:  Gastroenterology       Date:  1997-08       Impact factor: 22.682

9.  Prevention of delayed emesis by a single intravenous bolus dose of 5-HT3-receptor-antagonist in moderately emetogenic chemotherapy.

Authors:  B Massidda; M T Ionta
Journal:  J Chemother       Date:  1996-06       Impact factor: 1.714

10.  Nausea and vomiting in fractionated radiotherapy: a prospective on-demand trial of tropisetron rescue for non-responders to metoclopramide.

Authors:  R Miralbell; P Coucke; F Behrouz; N Blazek; M Melliger; S Philipp; R Wickenhauser; S Gebhard; T Schwabb; A Rosset
Journal:  Eur J Cancer       Date:  1995       Impact factor: 9.162

View more
  90 in total

1.  Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats.

Authors:  Thomas J Hopkins; Laura E Rupprecht; Matthew R Hayes; Julie A Blendy; Heath D Schmidt
Journal:  Neuropsychopharmacology       Date:  2012-06-06       Impact factor: 7.853

2.  Glucagon-like Peptide-1 receptor signaling in the lateral parabrachial nucleus contributes to the control of food intake and motivation to feed.

Authors:  Amber L Alhadeff; John-Paul Baird; Jennifer C Swick; Matthew R Hayes; Harvey J Grill
Journal:  Neuropsychopharmacology       Date:  2014-03-26       Impact factor: 7.853

3.  Brain Fos expression during 48 h after cisplatin treatment: neural pathways for acute and delayed visceral sickness.

Authors:  Charles C Horn; Marc Ciucci; Arun Chaudhury
Journal:  Auton Neurosci       Date:  2006-11-07       Impact factor: 3.145

4.  Mechanism of the prostanoid TP receptor agonist U46619 for inducing emesis in the ferret.

Authors:  Kelvin K W Kan; Man P Ngan; Man K Wai; John A Rudd
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-11       Impact factor: 3.000

Review 5.  Pontine respiratory activity involved in inspiratory/expiratory phase transition.

Authors:  Michael Mörschel; Mathias Dutschmann
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2009-09-12       Impact factor: 6.237

6.  How to Create Conditioned Taste Aversion for Grazing Ground Covers in Woody Crops with Small Ruminants.

Authors:  Carmen L Manuelian; Elena Albanell; Maristela Rovai; Gerardo Caja
Journal:  J Vis Exp       Date:  2016-04-30       Impact factor: 1.355

Review 7.  Why is the neurobiology of nausea and vomiting so important?

Authors:  Charles C Horn
Journal:  Appetite       Date:  2007-10-11       Impact factor: 3.868

8.  Incretins and amylin: neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose.

Authors:  Matthew R Hayes; Elizabeth G Mietlicki-Baase; Scott E Kanoski; Bart C De Jonghe
Journal:  Annu Rev Nutr       Date:  2014-04-10       Impact factor: 11.848

9.  Peptide YY3-36 and 5-hydroxytryptamine mediate emesis induction by trichothecene deoxynivalenol (vomitoxin).

Authors:  Wenda Wu; Melissa A Bates; Steven J Bursian; Brenna Flannery; Hui-Ren Zhou; Jane E Link; Haibin Zhang; James J Pestka
Journal:  Toxicol Sci       Date:  2013-03-01       Impact factor: 4.849

10.  Liraglutide pharmacotherapy reduces body weight and improves glycaemic control in juvenile obese/hyperglycaemic male and female rats.

Authors:  Claudia G Liberini; Rinzin Lhamo; Misgana Ghidewon; Tyler Ling; Nina Juntereal; Jack Chen; Anh Cao; Lauren M Stein; Matthew R Hayes
Journal:  Diabetes Obes Metab       Date:  2018-12-21       Impact factor: 6.577

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.